
The Federal Trade Commission (FTC) has taken action against the three largest pharmacy benefit managers (PBMs) in the United States, accusing them of manipulating the insulin market to prioritize their profits over patient affordability. The lawsuit, filed against UnitedHealth Group’s Optum Rx, CVS Health’s Caremark, and Cigna’s Express Scripts, alleges... Read More »